British American Tobacco’s Velo Push Hits FDA Delay as U.S. Nicotine Pouch Reviews Stall
British American Tobacco’s U.S. launch of Velo nicotine pouches faces delays as the FDA has not yet approved several products under its fast-track review, Reuters reported. BAT’s applications remain unresolved despite expectations for decisions by end-2025. The company relies on smoke-free products to offset falling cigarette sales and reported 2025 new-category revenue up 7% to £3.62 billion. FDA scientists have cited concerns about youth addiction risks.